481 results on '"Fromenty, Bernard"'
Search Results
102. A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen
103. Mid-infrared fibre evanescent wave spectroscopy of serum allows fingerprinting of the hepatic metabolic status in mice
104. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis
105. The effect of water suppression on the hepatic lipid quantification, as assessed by the LCModel, in a preclinical and clinical scenario
106. Chronic and low exposure to a pharmaceutical cocktail induces mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean and obese mice.
107. Letter to the Editor Regarding the Article Rotenone Increases Isoniazid Toxicity but Does Not Cause Significant Liver Injury: Implications for the Hypothesis that Inhibition of the Mitochondrial Electron Transport Chain Is a Common Mechanism of Idiosyncratic Drug-Induced Liver Injury by Cho and Co-Workers, 2019
108. Drug-Induced Microvesicular Steatosis and Steatohepatitis
109. Mitochondrial Injury and NASH
110. Features and Mechanisms of Drug-Induced Liver Injury
111. A cellular model to study acetaminophen-induced hepatotoxicity in the context of nonalcoholic fatty liver disease
112. Mitochondrial dysfunctions in liver due to environmental drug contaminants and obesity
113. Modulation of Metabolizing Enzymes by Bisphenol A in Human and Animal Models
114. Prediction of drug-induced liver injury in human with a multiparametric assay on the HepaRG® cell line
115. Administration of very low doses of water pharmaceutical contaminants in lean and obese mice disturbs the hepatic expression of genes involved in circadian rhythm
116. Drug-induced liver injury in obesity
117. Low doses of water pharmaceutical contaminants disturb hepatic gene expression in mice
118. Differences in Early Acetaminophen Hepatotoxicity between Obeseob/obanddb/dbMice
119. Central role of mitochondria in drug-induced liver injury
120. Increased Susceptibility to Liver Fibrosis with Age Is Correlated with an Altered Inflammatory Response
121. Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
122. Evaluation of drug toxicity using isolated mouse liver mitochondria
123. MnSOD Overexpression Prevents Liver Mitochondrial DNA Depletion after an Alcohol Binge but Worsens This Effect after Prolonged Alcohol Consumption in Mice
124. Hepatic Mitochondrial DNA Depletion after an Alcohol Binge in Mice: Probable Role of Peroxynitrite and Modulation by Manganese Superoxide Dismutase
125. Protection against Hepatocyte Mitochondrial Dysfunction Delays Fibrosis Progression in Mice
126. Effects of β-aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity
127. Chronic Ethanol Consumption Lessens the Gain of Body Weight, Liver Triglycerides, and Diabetes in Obese ob/ob Mice
128. β-Aminoisobutyric Acid Prevents Diet-induced Obesity in Mice With Partial Leptin Deficiency
129. High hepatic glutathione stores alleviate Fas-induced apoptosis in mice
130. Tamoxifen Inhibits Topoisomerases, Depletes Mitochondrial DNA, and Triggers Steatosis in Mouse Liver
131. Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors
132. High Doses of Stavudine Induce Fat Wasting and Mild Liver Damage without Impairing Mitochondrial Respiration in Mice
133. Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
134. Alcohol increases tumor necrosis factor α and decreases nuclear factor-κb to activate hepatic apoptosis in genetically obese mice
135. Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes
136. Mitochondrial injury in steatohepatitis
137. Effects of Zidovudine, Stavudine and β-Aminoisobutyric Acid on Lipid Homeostasis in Mice: Possible Role in Human Fat Wasting
138. Adipocytes Targets and Actors in the Pathogenesis of HIV-Associated Lipodystrophy and Metabolic Alterations
139. Mitochondrial and Metabolic Effects of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in Mice Receiving One of Five Single- and Three Dual-NRTI Treatments
140. NAFLD et dysfonction mitochondriale
141. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice
142. Effects of Alcohol and Oxidative Stress on Liver Pathology: The Role of the Mitochondrion
143. V. Mitochondrial dysfunction in steatohepatitis
144. Modulation of MetabolizingEnzymes by Bisphenol Ain Human and Animal Models.
145. Aggravation des hépatopathies liées à l’obésité par les xénobiotiques.
146. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice
147. PREMATURE OXIDATIVE DAMAGE TO HEPATIC MITOCHONDRIAL DNA IN ALCOHOLIC PATIENTS WITH MICROVESICULAR STEATOSIS
148. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes
149. High proportions of mtDNA duplications in patients with Kearns-Sayre syndrome occur in the heart
150. Deletions in mitochondrial DNA (mt-DNA) during hypoxic cell death in the human NT2-N neuronal cell line
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.